Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News and Insights

Showing items 1 to3 of 6

Categories
Tags
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take: Drugstore chains claim ‘Pharmageddon’ had minimal impact on stores, say they’re listening to workers
Insight
Our Take Newsletter
November 6, 2023

Our Take: Drugstore chains claim ‘Pharmageddon’ had minimal impact on stores, say they’re listening to workers

Learn More
November 6, 2023
pharma
pharmacy
drugstore
Our Take: Lilly scores FDA approval of tirzepatide for weight management, intensifying rivalry with Novo Nordisk
Insight
Our Take Newsletter
November 13, 2023

Our Take: Lilly scores FDA approval of tirzepatide for weight management, intensifying rivalry with Novo Nordisk

Learn More
November 13, 2023
fda
triple aim
health
care management
Our Take: Vertex, CRISPR Therapeutics gain first-ever approval of CRISPR-based gene-edited therapy
Insight
Our Take Newsletter
November 20, 2023

Our Take: Vertex, CRISPR Therapeutics gain first-ever approval of CRISPR-based gene-edited therapy

Learn More
November 20, 2023
gene therapy
advertisement
generics
generic drug
Our Take: AbbVie to acquire ImmunoGen for $10 billion, adding ADC for ovarian cancer to its portfolio
Insight
Our Take Newsletter
December 4, 2023

Our Take: AbbVie to acquire ImmunoGen for $10 billion, adding ADC for ovarian cancer to its portfolio

Learn More
December 4, 2023
immunotherapy
drug
cancer
AbbVie announces another multibillion dollar acquisition, while Roche jumps into the GLP-1 rivalry
Insight
Our Take Newsletter
December 11, 2023

AbbVie announces another multibillion dollar acquisition, while Roche jumps into the GLP-1 rivalry

Learn More
December 11, 2023
multicare health system
health
global
prescription drugs
2023 In Review: More multibillion-dollar acquisitions, early AI use, a historic drug approval, and more
Insight
Our Take Newsletter
December 18, 2023

2023 In Review: More multibillion-dollar acquisitions, early AI use, a historic drug approval, and more

Learn More
December 18, 2023
funding
drug
multicare health system
drugs
Merger updates: Several regional mergers are completed, one is called off, and a new one is proposed
Insight
Our Take Newsletter
January 8, 2024

Merger updates: Several regional mergers are completed, one is called off, and a new one is proposed

Learn More
January 8, 2024
merger
emerge
greatcall
caregiver
Our Take: Novartis takes a pass on acquiring Cytokinetics during a week of Big Pharma deals
Insight
Our Take Newsletter
January 15, 2024

Our Take: Novartis takes a pass on acquiring Cytokinetics during a week of Big Pharma deals

Learn More
January 15, 2024
compassus
pharma
pharmacy
pharmaceuticals
Our Take: General Catalyst’s HATCo selects Summa Health as its intended ‘blueprint’ for transforming health care
Insight
Our Take Newsletter
January 22, 2024

Our Take: General Catalyst’s HATCo selects Summa Health as its intended ‘blueprint’ for transforming health care

Learn More
January 22, 2024
health
general motors
hackensack
Our Take: Financial distress fueled increase in hospital and health system M&A activity in 2023, report indicates
Insight
Our Take Newsletter
January 29, 2024

Our Take: Financial distress fueled increase in hospital and health system M&A activity in 2023, report indicates

Learn More
January 29, 2024
finance
hospital
health system
healthcare
Our Take: Cigna agrees to sell its Medicare business to HCSC for $3.7 billion
Insight
Our Take Newsletter
February 5, 2024

Our Take: Cigna agrees to sell its Medicare business to HCSC for $3.7 billion

Learn More
February 5, 2024
medicare
medicine
amedisys
care management
care
Our Take: CVS Health lowers its guidance for 2024, citing medical cost trends
Insight
Our Take Newsletter
February 12, 2024

Our Take: CVS Health lowers its guidance for 2024, citing medical cost trends

Learn More
February 12, 2024
health system strategy
health
medicare
medicine
cost
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.